1. Home
  2. EXTR vs NVAX Comparison

EXTR vs NVAX Comparison

Compare EXTR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Extreme Networks Inc.

EXTR

Extreme Networks Inc.

HOLD

Current Price

$15.09

Market Cap

2.0B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.16

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXTR
NVAX
Founded
1996
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
EXTR
NVAX
Price
$15.09
$8.16
Analyst Decision
Strong Buy
Hold
Analyst Count
5
9
Target Price
$21.20
$11.33
AVG Volume (30 Days)
1.2M
3.7M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
90.91
309.76
EPS
0.10
2.58
Revenue
$1,140,067,000.00
$1,123,479,000.00
Revenue This Year
$13.15
N/A
Revenue Next Year
$7.52
N/A
P/E Ratio
$149.80
$3.14
Revenue Growth
2.05
64.69
52 Week Low
$10.11
$5.01
52 Week High
$22.89
$11.85

Technical Indicators

Market Signals
Indicator
EXTR
NVAX
Relative Strength Index (RSI) 55.04 36.55
Support Level $13.97 $8.01
Resistance Level $15.80 $8.45
Average True Range (ATR) 0.42 0.57
MACD 0.06 -0.28
Stochastic Oscillator 63.39 15.51

Price Performance

Historical Comparison
EXTR
NVAX

About EXTR Extreme Networks Inc.

Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: